Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 4/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL160953 | 0.78 | HSD11B1 (0.48) | HSD11B1CYP2C9L3MBTL1HSD17B10TSHR | |
| SCHEMBL19859959 | 0.78 | HSD11B1 (0.48) | HSD11B1CYP2C9L3MBTL1HSD17B10TSHR | |
| SCHEMBL16698251 | 0.78 | HSD11B1 (0.48) | HSD11B1CYP2C9L3MBTL1HSD17B10TSHR | |
| SCHEMBL28134787 | 0.76 | HSD11B1 (0.46) | HSD11B1CYP2C9L3MBTL1HSD17B10TSHR | |
| SCHEMBL28134798 | 0.76 | HSD11B1 (0.46) | HSD11B1CYP2C9L3MBTL1HSD17B10TSHR | |
| SCHEMBL31349739 | 0.76 | HSD11B1 (0.46) | HSD11B1CYP2C9L3MBTL1HSD17B10TSHR | |
| SCHEMBL27917064 | 0.76 | HSD11B1 (0.46) | HSD11B1CYP2C9L3MBTL1HSD17B10TSHR | |
| Hydrochloric Acid SCHEMBL3051989 | 0.76 | HSD11B1 (0.46) | HSD11B1CYP2C9L3MBTL1HSD17B10TSHR | |
| SCHEMBL28134791 | 0.76 | HSD11B1 (0.46) | HSD11B1CYP2C9L3MBTL1HSD17B10TSHR | |
| SCHEMBL15772802 | 0.76 | HSD11B1 (0.46) | HSD11B1CYP2C9L3MBTL1HSD17B10TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2611770-A1 | PROCESS FOR THE REDUCTIVE AMINATION OF -KETO CARBOXYLIC ACIDS | Sandoz AG (CH) | 2013-07-10 | — | — | EP | claimed |
| WO-2012028721-A1 | PROCESS FOR THE REDUCTIVE AMINATION OF α-KETO CARBOXYLIC ACIDS | SANDOZ AG (CH) | 2012-03-08 | — | — | WO | claimed |
| CN-105461540-A | Preparation method of saxagliptin intermediate (A1) | NANJING CRATER SCIENCE AND TECH INFORMATION CONSULTING CO LTD | 2016-04-06 | — | — | CN | disclosed |
| CN-104817476-A | Preparation method for unnatural amino acids | UNIV CHONGQING MEDICAL | 2015-08-05 | — | — | CN | disclosed |
| CN-104496799-A | Preparation method of 2-(3-hydroxyl-1-adamantyl)-2-formylformic acid | LIANYUNGANG TECHNICAL COLLEGE | 2015-04-08 | — | — | CN | disclosed |
| EP-2611770-A1 | PROCESS FOR THE REDUCTIVE AMINATION OF -KETO CARBOXYLIC ACIDS | Sandoz AG (CH) | 2013-07-10 | — | — | EP | disclosed |
| WO-2012028721-A1 | PROCESS FOR THE REDUCTIVE AMINATION OF α-KETO CARBOXYLIC ACIDS | SANDOZ AG (CH) | 2012-03-08 | — | — | WO | disclosed |